Live News Categoriesequity

Orexo AB (publ) (ORX.ST) News

Track canonical SquawkNews coverage tagged to ORX.ST, Orexo AB (publ). This hub brings together deduplicated headlines about stockholm, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol ORX.ST Asset equity Sector Markets 90 days 1 Last 13.46 Updated Sep 29, 2026, 01:46 PM UTC Open live news feed

M Orexo resubmits IZIPRY naloxone nasal powder NDA to FDA for opioid overdose treatment Orexo said it completed its FDA resubmission of the IZIPRY (naloxone nasal powder) NDA on Sept. 29, 2026, addressing deficiencies cited in a July 2024 complete response letter. FDA acceptance decision and an updated revi REGULATION | Sep 29, 2026, 01:46 PM UTC